Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the osteoarthritis therapeutics market grown over the years?
The osteoarthritis therapeutics market has experienced strong growth in recent years. It is expected to grow from $8.17 billion in 2024 to $8.87 billion in 2025, with a CAGR of 8.6%. The past growth resulted from an aging population, advancements in drug delivery systems, greater awareness and diagnosis, the development of novel therapies, and increasing obesity rates.
What Is the forecasted market size and growth rate for the osteoarthritis therapeutics market?
The osteoarthritis therapeutics market is expected to witness strong growth, reaching $12.22 billion by 2029 at a CAGR of 8.3%. Growth will be driven by rising obesity rates, improvements in treatment modalities, increasing awareness and diagnosis, development of disease-modifying osteoarthritis drugs (DMOADs), and government and private funding for research. Key trends include a focus on personalized medicine, regenerative therapy emergence, expanded pain management options, regulatory support, and increasing demand in emerging markets.
Get your osteoarthritis therapeutics market report here!
https://www.thebusinessresearchcompany.com/report/osteoarthritis-therapeutics-global-market-report
What are the major factors driving growth in the osteoarthritis therapeutics market?
Rising sports injuries are expected to drive the growth of the osteoarthritis therapeutics market. Increased participation in sports activities and the competitive nature of these sports have led to a rise in injuries, including joint degeneration. Osteoarthritis therapeutics help manage pain and improve joint function in athletes. The National Safety Council reported in 2022 that sports and recreational injuries rose by 12%, further boosting the demand for osteoarthritis therapeutics.
What key areas define the segmentation of the global osteoarthritis therapeutics Market?
The osteoarthritis therapeuticsmarket covered in this report is segmented –
1) Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Other Drug Types
2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs
5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-uses
Subsegments:
1) Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products
2) Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors
3) Analgesics: Opioid Analgesics, Non-Opioid Analgesics, Topical Analgesics
4) Corticosteroids: Injectable Corticosteroids, Oral Corticosteroids, Intra-Articular Corticosteroids
5) Other Drug Types: Disease-Modifying Osteoarthritis Drugs (DMOADs), Platelet-Rich Plasma Therapy, Stem Cell Therapy
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19634&type=smp
What are the top market players propelling the growth of the osteoarthritis therapeutics industry?
Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Zimmer Biomet Holdings Inc., Horizon Therapeutics plc, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Galapagos NV, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Samumed LLC, Orthogen AG, Kolon Life Science Inc.
What are the key trends shaping the future of the osteoarthritis therapeutics market?
Major firms in the osteoarthritis therapeutics market are concentrating on the creation of novel solutions, emphasizing on inventive tissue regeneration methods for osteoarthritis. Tissue repair in osteoarthritis involves the restoration or replacement of harmed cartilage and joint tissues in order to regain normality and diminish pain. For example, in May 2023, the US government agency, the Advanced Research Projects Agency for Health (ARPA-H), announced its Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program. This program by ARPA-H is centered around developing revolutionary injectable treatments that promote cartilage restoration utilizing biological pathways aligned with those employed during embryonic growth. The program is characterized by a cooperative multimodal approach amongst research groups, coupled with state-of-the-art testing methods such as “joint-on-a-chip” technologies to simulate joint conditions with the goal of innovating regenerative solutions for the underlying causes of osteoarthritis.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19634
What regions are dominating the osteoarthritis therapeutics market growth?
North America was the largest region in the osteoarthritis therapeutics market in 2022. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Leukemia Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report
Biosimilar Therapeutic Peptides Global Market Report 2024
Antisense & RNAi Therapeutics Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
